Scott Jordan

Head Corporate Development

An accomplished senior-level executive with over 30 years of experience and successful track records in the life sciences industry.
Worked as Chief Business Officer for Inomagen Therapeutics and Salarius Pharmaceuticals.
Secured $2.6M in capital from an Equity Line sponsored by Aspire Capital for Salarius Pharmaceuticals and closed a $48M Reverse Merger with Flex Pharma listing the company on NASDAQ in 2019.
BA in Marketing from Michigan State University and an MBA from the Kellstadt Graduate School of Business at DePaul University.